MM-401 | CAS No. 1442106-10-6

Sale

MM-401 | CAS No. 1442106-10-6

Original price was: $32.00.Current price is: $26.00.

MM-401 is a selective MLL1 inhibitor that blocks the interaction of MLL1 with WDR5, thereby inhibiting H3K4 methyltransferase activity. This results in cell cycle arrest and apoptosis in leukemic cells. Both the free form and its TFA salt form exhibit comparable biological activity, although the salt form demonstrates superior solubility and stability.

EMI starting from $0.00/month - View Plans
Compare
Category: Tag:

Description

Product Description

MM-401 (CAS 1442106-10-6) is a small-molecule inhibitor specifically designed to disrupt the MLL1–WDR5 protein-protein interaction, a crucial step in the regulation of histone H3 lysine 4 (H3K4) methylation. This epigenetic mark plays a central role in regulating gene expression, and its dysregulation has been strongly linked to mixed lineage leukemia (MLL) and other cancers.

Background on MLL1 and Epigenetic Regulation

  • MLL1 (Mixed-Lineage Leukemia 1) is a histone methyltransferase that catalyzes H3K4 methylation, an epigenetic modification associated with transcriptional activation.

  • MLL1 functions within a multi-protein complex requiring co-factors such as WDR5, RbBP5, and ASH2L.

  • Dysregulation of MLL1 activity leads to aberrant transcription of genes involved in hematopoietic differentiation and oncogenesis.

Role of MM-401 in Research

  1. Leukemia Studies

    • MLL-rearranged leukemias are aggressive hematological malignancies with poor prognosis.

    • MM-401 selectively inhibits leukemic cell growth by targeting MLL1-WDR5 interactions.

    • Promotes cell cycle arrest, apoptosis, and differentiation of leukemic blasts.

  2. Epigenetic Mechanism Exploration

    • Serves as a model compound for understanding histone methyltransferase biology.

    • Helps delineate the role of H3K4 methylation in transcription regulation.

  3. Drug Discovery Tool

    • Acts as a chemical probe to validate the therapeutic potential of disrupting MLL complexes.

    • Guides development of next-generation MLL1 inhibitors.

  4. Free Form vs. Salt Form (MM-401 TFA)

    • Both demonstrate equivalent biological activity at equimolar concentrations.

    • TFA salt form provides enhanced water solubility and chemical stability, making it more suitable for biological assays.


Product Specifications

ItemDetails
Product NameMM-401
CAS No.1442106-10-6
SynonymsMLL1-WDR5 interaction inhibitor, MM-401 TFA (salt form)
TargetMLL1 H3K4 methyltransferase
IC500.32 μM (MLL1-WDR5 disruption)
Molecular TypeSmall-molecule inhibitor
AppearanceSolid powder
Purity≥95% (HPLC)
SolubilitySoluble in DMSO, aqueous buffers (TFA salt more soluble)
Storage-20°C to -80°C, desiccated, protected from light
StabilityStable for 12 months under recommended conditions
ApplicationsLeukemia research, epigenetic regulation, chemical probe studies

Notes

  • Supplied in both free and TFA salt forms.

  • Endotoxin-free.

  • For research use only.


Mechanism of Action

MM-401 functions by selectively blocking the interaction of MLL1 with WDR5, thereby inhibiting MLL1-mediated methylation of histone H3 at lysine 4 (H3K4).

  1. Disruption of MLL1-WDR5 Interaction

    • WDR5 is essential for stabilizing MLL1 complex formation.

    • MM-401 binds to the WDR5 interaction site, preventing recruitment of MLL1.

  2. Inhibition of H3K4 Methylation

    • Loss of MLL1 activity reduces H3K4 trimethylation.

    • Leads to downregulation of genes critical for leukemogenesis, such as HOXA9 and MEIS1.

  3. Cell Cycle Arrest

    • Inhibition of transcriptional programs controlled by MLL1 halts proliferation.

    • Leukemic cells undergo G0/G1 arrest.

  4. Induction of Apoptosis

    • Triggered by downregulation of survival genes.

    • Leads to caspase activation and programmed cell death.

  5. Differentiation of Leukemic Cells

    • By relieving epigenetic blocks, MM-401 promotes terminal differentiation.

  6. Epigenetic Selectivity

    • Unlike global histone methyltransferase inhibitors, MM-401 is highly selective for the MLL1-WDR5 interaction.

    • Minimizes off-target effects and provides a precise research tool.

      image-mm-401-chemical-structure-supplier


Side Effects

Research Observations

  • Demonstrates high selectivity for MLL1-WDR5 with minimal off-target inhibition.

  • Reduces leukemic cell viability while sparing most normal hematopoietic cells.

Potential Research Risks

  • Prolonged exposure may alter gene expression landscapes in non-leukemic cells.

  • Possible cytotoxicity at high concentrations.

  • Stability of the free form is lower compared to TFA salt.

Laboratory Safety Notes

  • For laboratory research only.

  • Handle under sterile conditions.

  • Store in recommended conditions to preserve activity.


Disclaimer

This product is intended for research purposes only. MM-401 is not approved for clinical or diagnostic use in humans.


Keywords

MM-401, CAS 1442106-10-6, MLL1 inhibitor, WDR5-MLL1 interaction blocker, H3K4 methyltransferase inhibitor, MM-401 TFA, leukemia research compound, epigenetic inhibitor.china low price supplier 


Shipping Guarantee

We provide reliable global shipping services:

  • Customs-Cleared & Tax-Inclusive deliveries.

  • 100% Compensation for any loss or damage in transit.

  • Trackable and efficient international logistics.


Transaction Guarantee

We support secure and flexible payment methods:

  • T/T bank transfer

  • PayPal

  • Cryptocurrency (BTC, ETH, USDT, etc.)

  • Additional methods available on request

We ensure safe, transparent, and convenient transactions for all research products.

Additional information

Weight0.6 kg
Dimensions56 × 52 × 56 cm

Reviews

There are no reviews yet.

Be the first to review “MM-401 | CAS No. 1442106-10-6”

Your email address will not be published. Required fields are marked *

What is MM-401?

It is a small-molecule inhibitor of the MLL1-WDR5 interaction, studied in leukemia research.

What is its CAS number?

1442106-10-6.

What is MM-401 used for?

It is primarily applied in MLL leukemia and epigenetic research.

What is the IC50 of MM-401?

0.32 μM for disruption of MLL1-WDR5 interaction.

How does MM-401 work?

It blocks MLL1-WDR5 interaction, inhibiting H3K4 methylation and leading to apoptosis and differentiation of leukemic cells.

Is MM-401 selective?

Yes, it selectively targets MLL1-WDR5, minimizing off-target effects.

What is the difference between MM-401 free form and MM-401 TFA?

Both are biologically active, but the TFA salt form provides enhanced solubility and stability.

What are the effects of MM-401 on cells?

It induces cell cycle arrest, apoptosis, and differentiation in leukemic cells.

What purity is MM-401 provided at?

≥95% confirmed by HPLC.

How should MM-401 be stored?

At -20°C to -80°C, desiccated, protected from light.

Is MM-401 approved for human use?

No, it is strictly for research purposes only.


EMI Options

Select at least 2 products
to compare